Impact of Aspirin versus Clopidogrel Treatment on the Prevention of Recurrent Events in Patients with Ischemic Stroke
DOI:
https://doi.org/10.56294/shp2025209Keywords:
aspirin, clopidogrel, ischemic stroke, recurrent prevention, randomized controlled trialAbstract
Background: Ischemic stroke is a leading cause of global morbidity and mortality. Secondary prevention is essential to reduce the recurrence of events. This study compares the efficacy and safety of aspirin versus clopidogrel in preventing recurrent events in patients with ischemic stroke.
Materials and Methods: A systematic review and meta-analysis of randomized controlled trials published between 2004 and 2024 was conducted. Studies comparing aspirin and clopidogrel in adult patients with ischemic stroke were included.
Results: Eleven studies involving 77,216 patients were analyzed. Clopidogrel significantly reduced the recurrence of stroke compared to aspirin (RR 0.86; 95% CI, 0.75–0.98). No significant differences were found in the rate of serious adverse events between the two treatments. Conclusion: Clopidogrel, as monotherapy, proves to be more effective than aspirin in preventing recurrent events in patients with ischemic stroke, without a significant increase in severe adverse events. However, dual therapy may offer additional benefits for some patients, albeit at the cost of an increased risk of bleeding. These findings suggest that clopidogrel is a preferred option for secondary prevention, with careful assessment of the risk-benefit profile in specific cases.
References
Organización Mundial de la Salud. Informe sobre la carga mundial de morbilidad. Ginebra: OMS; 2020.
Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008 May 10;371(9624):1612-23. doi:10.1016/S0140-6736(08)60694-7.
Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017 Feb 3;120(3):439-48. doi:10.1161/CIRCRESAHA.116.308413.
Deb P, Sharma S, Hassan KM. Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance of cytoprotective agents. Int J Clin Exp Pathol. 2010;3(1):38-50. doi:10.17140/ijcep.v3i1.2576.
Chamorro Á, Dirnagl U, Urra X, Planas AM. Neuroprotective therapies after stroke: From promise to disappointment. Lancet Neurol. 2016 May;15(7):917-28. doi:10.1016/S1474-4422(16)00120-9.
Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul;45(7):2160-236. doi:10.1161/STR.0000000000000024.
Hankey GJ. Secondary stroke prevention. Lancet Neurol. 2014 Feb;13(2):178-94. doi:10.1016/S1474-4422(13)70255-2.
Patrono C, García Rodríguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005 Jan 20;352(3):237-49. doi:10.1056/NEJMra040893.
Gurbel PA, Tantry US. Clopidogrel resistance? Thromb Res. 2007;120(3):311-21. doi:10.1016/j.thromres.2006.10.001.
Geeganage C, Diener HC, Algra A, et al. Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: A systematic review and meta-analysis. Stroke. 2012;43(4):1058-66. doi:10.1161/STROKEAHA.112.668572.
Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11-9. doi:10.1056/NEJMoa1213072.
Wang Y, Meng X, Wang A, et al. Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke. Neurology. 2015;85(7):573-9. doi:10.1212/WNL.0000000000001627.
Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215-25. doi:10.1056/NEJMoa1800410.
Chi NF, Chien LN, Ku HL, et al. Comparison between aspirin and clopidogrel in secondary stroke prevention: A national cohort study (Taiwan Stroke Registry). PLoS One. 2018;13(10):e0205182. doi:10.1371/journal.pone.0205182.
Benavente OR, Hart RG, McClure LA, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke (SPS3). N Engl J Med. 2012;367(9):817-25. doi:10.1056/NEJMoa1111474.
Published
Issue
Section
License
Copyright (c) 2025 Aline de Moura Fernandes, Adolfo Savia (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
